Sort by topic:

Episode 12: Value of Specialty Pharmacy in Oncology


 
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss the value that specialty pharmacies can bring to the field of oncology.  
 
Of all of the drugs that have been approved in the past 2 years, 22 of them have been for oncology. In the past, many oncology medications were infused in the provider’s office, but now that so many novel oncology drugs are oral, the touch point has shifted from the provider to the specialty pharmacy, according to Allen. The panelists agreed that specialty pharmacies can provide value in the oncology space by utilizing proactive side effect mitigation strategies, such as side effect management kits and tip cards that patients and providers can refer to. Specialty pharmacies can function as a liaison to coordinate communication between the patient and the provider, Ness said.
 
As more of these new oncology drugs are approved, Allen noted, the benefit investigation conducted by the specialty pharmacy will have a great impact on the patient experience. Rayberg said that providers and patients are excited by the new drugs and new mechanisms of action, but payors have the burden of understanding all of the new options and combinations while keeping use on label when possible.  
 
*The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc. 
 
 


Episode #1

Episode 1: What is Specialty Pharmacy?
Episode 1: What is Specialty Pharmacy?

Episode #2

Episode 2: Understanding and Exploring the Practice of Specialty Pharmacy: How is quality measured?
Episode 2: Understanding and Exploring the Practice of Specialty Pharmacy: How is quality measured?

Episode #3

Episode 3: How Do Prior Authorization and Cost Impact Patient Care?
Episode 3: How Do Prior Authorization and Cost Impact Patient Care?

Episode #4

Episode 4 - Navigating Barriers to Therapy and Reimbursement
Episode 4 - Navigating Barriers to Therapy and Reimbursement

Episode #5

Episode 6: Evaluating Specialty Pharmacy: Reliable Methods to Measure Quality
Episode 6: Evaluating Specialty Pharmacy: Reliable Methods to Measure Quality

Episode #6

Episode 5: Is There Value to Specialty Pharmacy Accreditation?
Episode 5: Is There Value to Specialty Pharmacy Accreditation?

Episode #7

Episode 7: Data Aggregation in Specialty Pharmacy
Episode 7: Data Aggregation in Specialty Pharmacy

Episode #8

Episode 8: New Products and Limited Distribution Channels
Episode 8: New Products and Limited Distribution Channels

Episode #9

Episode 9: Role of Biosimilars in the Specialty Marketplace
Episode 9: Role of Biosimilars in the Specialty Marketplace

Episode #10

Episode 10: How Do We Know Specialty Pharmacies Are Providing Good Customer Service?
Episode 10: How Do We Know Specialty Pharmacies Are Providing Good Customer Service?

Episode #11

Episode 11: Management of High Cost Medications
Episode 11: Management of High Cost Medications

Episode #12

Episode 12: Value of Specialty Pharmacy in Oncology
Episode 12: Value of Specialty Pharmacy in Oncology

Episode #13

Episode 13: Challenges of Medication Adherence in the Oncology Population
Episode 13: Challenges of Medication Adherence in the Oncology Population

Episode #14

Episode 14: Strategies to Mitigate Side Effects and Management of Comorbidities
Episode 14: Strategies to Mitigate Side Effects and Management of Comorbidities

Episode #15

Episode 15: Are High Cost Hepatitis C Medications Worth the Price Tag?
Episode 15: Are High Cost Hepatitis C Medications Worth the Price Tag?

Episode #16

Episode 16: Encouraging Medication Adherence in Hepatitis C
Episode 16: Encouraging Medication Adherence in Hepatitis C

Episode #17

Segment 17: Managing Depression: Use of Counseling to Improve Outcomes
Segment 17: Managing Depression: Use of Counseling to Improve Outcomes

Episode #18

Segment 18: Hepatitis C Virus: Achieving an SVR and Unmet Patient Needs
Segment 18: Hepatitis C Virus: Achieving an SVR and Unmet Patient Needs
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$